| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.093 | 0.1 |